In recent elections, health care has been one of the most hot-button issues with consequences for millions of Americans, and this election is no exception. The next administration and the 119th Congress have the potential to...more
8/27/2024
/ Abortion ,
Affordable Care Act ,
Drug Pricing ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Inflation Reduction Act (IRA) ,
Medicaid ,
Medicare ,
Presidential Elections ,
Reproductive Healthcare Issues
The next three weeks will be full of activity in Washington D.C., as the House of Representatives and Senate are working to push their legislative agendas to garner support from their constituents ahead of an August recess...more
With the presidential transition underway, we now look forward to what the Biden administration will seek to accomplish, particularly in the realm of health care policy. President-elect Biden has been clear that he wants to...more
11/24/2020
/ Affordable Care Act ,
Biden Administration ,
California v Texas ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Insurance ,
Healthcare Reform ,
Lame Duck Session ,
Legislative Agendas ,
Prescription Drugs ,
Rutledge v Pharmaceutical Care Management Association ,
Trump Administration
In an exchange which has now gone viral, freshman U.S. Representative Katie Porter (D-Calif.) questioned former Celgene CEO Mark Alles about his 2017 compensation structure last week. Rep. Porter, who is now famous for...more
Welcome back. This week, the Senate Finance Committee is set to meet privately to discuss the drug pricing legislation being developed by the committee. All signs point to a deal being close with a few outstanding provisions,...more
This week, the full House is poised to take its first action on drug pricing, voting on a pair of bills that would improve access to drug patents. The first bill is H.R. 1520, the Purple Book Continuity Act of 2019, which...more
5/9/2019
/ Affordable Care Act ,
Congressional Budget Office ,
Drug Pricing ,
HELP ,
Legislative Agendas ,
Medicare Part D ,
Orange Book ,
Pharmaceutical Industry ,
Preexisting Conditions ,
Prescription Drugs ,
Purple Book
This week, the full House is poised to take its first action on drug pricing, voting on a pair of bills that would improve access to drug patents. The first bill is H.R. 1520, the Purple Book Continuity Act of 2019, which...more
5/8/2019
/ Affordable Care Act ,
Congressional Budget Office ,
Drug Pricing ,
Generic Drugs ,
Medicare Part D ,
Orange Book ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Regulatory Agenda
FDA Reform Tops Spring Work Period Agenda -
The next work period basically runs from April 4 to May 27, with a both chambers adjourning for a week long recess the week of May 2nd. Following this work period, there will...more
The next work period basically runs from April 4 to May 27, with both chambers adjourning for a week long recess the week of May 2. Following this work period, there will be five weeks left on the legislative calendar before...more
4/5/2016
/ 21st Century Cures Initiative ,
Congressional Committees ,
Drug Pricing ,
Federal Aviation Administration (FAA) ,
Home Healthcare Workers ,
Legislative Agendas ,
Medicare Advantage ,
Mental Health ,
NDAA ,
Water ,
Zika
The Administration is Ramping Up Drug Pricing Response -
The President’s budget makes clear for all to see that the Administration wants to do something related to drug pricing. Unfortunately for the Administration,...more
2/17/2016
/ 60-Day Rule ,
Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Congressional Committees ,
Drug Pricing ,
Federal Budget ,
Food and Drug Administration (FDA) ,
Justice Scalia ,
Overpayment ,
Prescription Drugs ,
Proposed Legislation ,
SCOTUS ,
Substance Abuse ,
Zika
Martin Shkreli Not the Big Story on the Hill Last Week -
Congress’s complex relationship with prescription drugs was on display last week in the House of Representatives. In the House Committee on Oversight and...more
2/16/2016
/ Affordable Care Act ,
Biosimilars ,
BPCIA ,
Cancer ,
Centers for Disease Control and Prevention (CDC) ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Drug Pricing ,
GDUFA ,
Martin Shkreli ,
Mental Health ,
Prescription Drugs ,
Telemedicine ,
Zika
Are Lawmakers and Stakeholders Ready for the Silver Tsunami? -
Last week, the Congressional Budget Office (CBO) released a projection that shows Medicare enrollment will grow by more than 30 percent in the next decade...more
2/16/2016
/ ACOs ,
Affordable Care Act ,
Alternative Payment Models (APM) ,
Congressional Budget Office ,
Drug Pricing ,
Elder Issues ,
FCC ,
Food and Drug Administration (FDA) ,
Healthcare Costs ,
Medical Debt ,
Medicare ,
Mental Health ,
Prescription Drugs ,
Substance Abuse ,
TCPA ,
Telemedicine
Cadillac Tax Repeal Garners Bipartisan Support; Prospects for Implementation Delay Increase -
Last week, the Senate passed its reconciliation package by a vote of 52-47, sending it back to the House for approval and...more
Drug Pricing Issues Heat Up Following HHS Forum -
Last week, the Department of Health and Human Services (HHS) hosted a forum on prescription drug costs which featured players from every corner of the industry, including...more
FDA Hosts Genome Scientists For Next-Generation Sequencing Conference -
Last week, the Food and Drug Administration (FDA) hosted genome scientists from across the nation at its campus in White Oak, Maryland. Two public...more
Ways & Means Leadership Changes – Health Policy Implications Looming:
As Congress pushes forward with a two-year budget deal, and new Speaker Paul Ryan begins his tenure as the top Republican in the House of...more
11/4/2015
/ 21st Century Cures Initiative ,
Affordable Care Act ,
Automatic Enrollment ,
Centers for Medicare & Medicaid Services (CMS) ,
Co-Op ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Contraceptive Coverage Mandate ,
Department of Justice (DOJ) ,
Department of Labor (DOL) ,
Drug Pricing ,
E-Cigarettes ,
Federal Budget ,
Food and Drug Administration (FDA) ,
FTEs ,
Generic Drugs ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare Reform ,
Home Health Care ,
Hospitals ,
ICD-10 ,
Medicare ,
Medicare Part B ,
MedPAC ,
Mental Health ,
New Legislation ,
Open Enrollment ,
OPPS ,
Prescription Drugs ,
Proposed Legislation ,
Rebates ,
Rulemaking Process ,
SCOTUS ,
Substance Abuse ,
Telehealth ,
Telemedicine ,
Tobacco Regulations ,
Two-Midnight Rule ,
U.S. Treasury
Senate Working Group Pressing Forward on Telehealth -
As Congress focuses on bigger picture policy decisions, including broad budget negotiations and raising the debt ceiling, there are some exciting developments on the...more
10/29/2015
/ Affordable Care Act ,
Alternative Payment Models (APM) ,
Barack Obama ,
Cadillac Tax ,
Co-Op ,
Congressional Committees ,
Congressional Investigations & Hearings ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
E-Cigarettes ,
Elder Issues ,
Federal Trade Commission (FTC) ,
Fee-for-Service ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Health Care Providers ,
Health Insurance ,
Healthcare ,
Medicare ,
Medicare Part B ,
Medicare Part D ,
Mental Health ,
Orphan Drugs ,
PACE ,
Prescription Drugs ,
SAMHSA ,
Section 340B ,
Social Security ,
State Health Insurance Exchanges ,
Substance Abuse ,
Telehealth ,
Telemedicine
Congress Slowly Works on Budget Reconciliation; ACA Reform Proposals Still Up in the Air -
The FY 2016 budget resolution, which was agreed to by Congress this past April, included broad reconciliation instructions...more
7/21/2015
/ Affordable Care Act ,
AHRQ ,
Budget Reconciliation ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Investigations & Hearings ,
Drug Pricing ,
Electronic Medical Records ,
Federal Budget ,
Fraud Prevention ,
GAO ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare.gov ,
Home Health Care ,
ICD-10 ,
Legislative Agendas ,
Long Term Care Facilities ,
Medicaid ,
Medical Records ,
Medicare ,
Mental Health ,
Obama Administration ,
OMB ,
ONC ,
Pending Legislation ,
Prescription Drugs ,
Regulatory Agenda ,
Telehealth ,
Telemedicine